Cited by 93Alzheimer's disease research and treatmentsProtein Structure and DynamicsDementia and Cognitive Impairment Research

Stabilization of Neurotoxic Soluble β-Sheet-Rich Conformations of the Alzheimer's Disease Amyloid-β Peptide

Open access
Tew, Deborah J., Bottomley, Stephen P., Smith, David P., Ciccotosto, Giuseppe D., Babon, Jeffrey, Hinds, Mark G., Masters, Colin L., Cappai, Roberto +1 more·2008·Biophysical Journal

Abstract

An emerging paradigm for degenerative diseases associated with protein misfolding, such as Alzheimer's disease, is the formation of a toxic species due to structural transitions accompanied by oligomerization. Increasingly, the focus in Alzheimer's disease is on soluble oligomeric forms of the amyloid-beta peptide (Abeta) as the potential toxic species. Using a variety of methods, we have analyzed how sodium dodecyl sulphate (SDS) modulates the folding of Abeta40 and 42 and found that submicellar concentrations of SDS solubilize Abeta and induce structural transitions. Under these conditions, Abeta40 and 42 are interconverting oligomeric ensembles with a predominantly beta-sheet structure. The Abeta42 soluble oligomers form beta-sheet structures more readily and have increased stability compared with Abeta40 under identical conditions. The presence of added Cu(2+) significantly promotes and stabilizes the formation of the soluble oligomeric beta-sheet structures but these structures are nonamyloidogenic. In contrast, in the absence of added Cu(2+), these beta-sheet oligomers possess the hallmarks of amyloidogenic structures. These SDS-induced beta-sheet forms of Abeta, both in the presence and absence of Cu(2+), are toxic to neuronal cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1529/biophysj.107.119909

Cites

0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Metal ions are able to stabilize the soluble Aβ42 oligomers and thus partially inhibit the Aβ42 aggregation.

    “These results suggest that metal ions are able to stabilize the soluble Aβ42 oligomers and thus partially inhibit the Aβ42 aggregation.89”

    From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ<sub>42</sub>Peptide (2012) · cites this paper as [89]

    The Conclusion (page unavailable) says Cu2+ promotes the formation and stability of soluble Aβ oligomers, supporting the stabilization part for copper. It does not report that metal ions generally partially inhibit Aβ42 aggregation; the Discussion instead describes increased aggregation under the study conditions. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM, while the Western blot shows the presence of higher order Aβ42 oligomers, likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.

    “The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM (Figure 10, panel a) while the Western blot shows the presence of higher order Aβ42 oligomers (Figure 10, lane a), likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.89–91”

    From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ<sub>42</sub>Peptide (2012) · cites this paper as [89]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 10

  1. [1]1. Masters, C.L. ∙ Simms, G. ∙ Weinman, N.A. ... Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. USA. 1985; 82:4245-4249 Crossref Scopus (3911) PubMed Google Scholar
  2. [2]2. Masters, C.L. ∙ Cappai, R. ∙ Barnham, K.J. ... Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics J. Neurochem. 2006; 97:1700-1725 Crossref Scopus (217) PubMed Google Scholar
  3. [3]3. Geula, C. ∙ Wu, C.K. ∙ Saroff, D. ... Aging renders the brain vulnerable to amyloid [β]-protein neurotoxicity Nat. Med. 1998; 4:827-831 Crossref Scopus (511) PubMed Google Scholar
  4. [4]4. Yankner, B.A. ∙ Duffy, L.K. ∙ Kirschner, D.A. Neurotrophic and neurotoxic effects of amyloidβ protein: reversal by tachykinin neuropeptides Science. 1990; 250:279-282 Crossref Scopus (1992) PubMed Google Scholar
  5. [5]5. Hendriks, L. ∙ van Duijn, C.M. ∙ Cras, P. ... Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene Nat. Genet. 1992; 1:218-221 Crossref Scopus (672) PubMed Google Scholar
  6. [6]6. Levy, E. ∙ Carman, M.D. ∙ Fernandez-Madrid, I.J. ... Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type Science. 1990; 248:1124-1126 Crossref Scopus (1174) PubMed Google Scholar
  7. [7]7. Miravalle, L. ∙ Tokuda, T. ∙ Chiarle, R. ... Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells J. Biol. Chem. 2000; 275:27110-27116 Full Text Full Text (PDF) PubMed Google Scholar
  8. [8]8. Nilsberth, C. ∙ Westlind-Danielsson, A. ∙ Eckman, C.B. ... The “Arctic” APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation Nat. Neurosci. 2001; 4:887-893 Crossref Scopus (986) PubMed Google Scholar
  9. [9]9. Grabowski, T.J. ∙ Cho, H.S. ∙ Vonsattel, J.P. ... Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy Ann. Neurol. 2001; 49:697-705 Crossref Scopus (447) PubMed Google Scholar
  10. [10]10. McLean, C.A. ∙ Cherny, R.A. ∙ Fraser, F.W. ... Soluble pool of Aβ amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease Ann. Neurol. 1999; 46:860-866 Crossref Scopus (1647) PubMed Google Scholar

Cited by

Sorted by citations

Authors
Tew, D. J., Bottomley, S. P., Smith, D. P., Ciccotosto, G. D., Babon, J., Hinds, M. G., Masters, C. L., Cappai, R., & Barnham, K. J.
Affiliations
  • Mental Health Research Institute (AU)
  • Monash University (AU)
  • Walter and Eliza Hall Institute of Medical Research (AU)
Corresponding author
Barnham, Kevin J.
Venue
Biophysical Journal
Publisher
Elsevier BV
Published
2008-04
Volume
94
Issue
7
Pages
2752-2766
ISSN
0006-3495 (ISSN-L)
OpenAlex
W1971525444
Cited by
93
References
63
Citations by year
2026: 2 · 2025: 1 · 2024: 5 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 4 · 2015: 2 · 2014: 1 · 2013: 7 · 2012: 9
FWCI
4.70
Type
journal article
Language
en
Open access
Locations
  • Biophysical Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
amyloid-beta, Alzheimer's disease, soluble oligomers, β-sheet conformation, sodium dodecyl sulfate, protein misfolding, copper(II) ions, neurotoxicity, Aβ40, amyloid-beta 42, structural phase transition
MeSH terms
Animals, Cell Survival, Cells, Cultured, Computer Simulation, Dose-Response Relationship, Drug, Models, Chemical, Models, Molecular, Neurons, Neurotoxins, Structure-Activity Relationship, Amyloid beta-Peptides, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review